Grotech Ventures Backs Innovative Information, Research and Technology Platform for Life Sciences Marketing, R&D and Medical Affairs
Charlottesville, VA, San Diego, CA, New York, NY and Paris, France (PRWeb) -- OpenQ, the industry leader in innovative tools for information and research for life sciences marketing, compliance, R&D and medical affairs announces that it has secured an equity investment from Grotech Ventures. The new capital will fuel an expansion of openQ into new markets and new research areas.
"We are thrilled to receive an investment and strategic guidance from a fund like Grotech, who has a track record of enabling technology, information and services for life sciences companies to grow and meet their full potential," stated Jim Zuffoletti, openQ President. "My co-founder, Otavio Freire, and I look forward to our continued partnership in securing openQ's position as a leader in its sector providing technology, information and research to life sciences companies around the world."
"Grotech is pleased to begin a collaboration with openQ to help the company extend their current leadership position as an innovator in life sciences technology and information. We are impressed with openQ's rapid growth and successful track record serving the largest pharmaceutical and the smallest biotechs with creative solutions to help ensure compliance, speed time to approval, and accelerate adoption," added Chuck Cullen, General Partner at Grotech.
The openQ Platfom
The openQ platform includes breakthrough tools and research to identify trends, organizations and key individuals who impact adoption and scientific dialogue while ensuring compliance. The company's easy to use technology provides instant access to vital market information updated in real time. The openQ platform includes the following on-demand information and sof
Copyright©2009 Vocus, Inc.
All rights reserved